StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

ANIK — Anika Therapeutics, Inc.

EXPENSIVE (MOS -69.7%) · Quality 55/100

Price
20.81
Intrinsic value
12.26
Margin of safety
-69.7%
Implied growth (reverse DCF)
+22.6%
model assumes +15.6%
Value Score
6.1
Quality
55
Psychology
-9.5
Discovery
12.6
price/volume attention only
Moat score
17
erosion: watch

Value Score: bottom 8% of Russell 3000 · Quality: top 46%

Open the interactive Deep Dive for ANIK →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ANIK - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ANIK undervalued?

As of 2026-09-19, ANIK trades at 20.81 against a computed intrinsic value of 12.26 (-69.7% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Anika Therapeutics, Inc.'s Value Score?

Anika Therapeutics, Inc.'s Value Score is 6.1 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.